These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38189735)

  • 1. Nomograms combining computed tomography-based body composition changes with clinical prognostic factors to predict survival in locally advanced cervical cancer patients.
    Fu B; Wei L; Wang C; Xiong B; Bo J; Jiang X; Zhang Y; Jia H; Dong J
    J Xray Sci Technol; 2024; 32(2):427-441. PubMed ID: 38189735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nomogram of Combining CT-Based Body Composition Analyses and Prognostic Inflammation Score: Prediction of Survival in Advanced Epithelial Ovarian Cancer Patients.
    Wang X; Zhang C; Cao F; Wang CB; Dong JN; Wang ZH
    Acad Radiol; 2022 Sep; 29(9):1394-1403. PubMed ID: 34955366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a nomogram based on body composition analysis of quantitative computed tomography combined with clinical prognostic factors to predict disease-free survival after surgery and adjuvant chemotherapy in patients with gastric cancer.
    Wei L; Fu B; Bo J; Jia H; Sun M; Jiang X; Wang T; Wang P; Dong J
    Quant Imaging Med Surg; 2023 Dec; 13(12):8489-8503. PubMed ID: 38106291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nomograms for predicting prognostic value of combined neutrophil-to-lymphocyte ratio and SCC-Ag in locally advanced cervical cancer.
    Jin L; Cao F; Zhang Y; Dang Y; Wang F
    Transl Cancer Res; 2024 Mar; 13(3):1323-1335. PubMed ID: 38617514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Body Composition Changes in Hepatocellular Carcinoma: Prediction of Survival to Transcatheter Arterial Chemoembolization in Combination With Clinical Prognostic Factors.
    Zheng X; Cao F; Qian L; Dong J
    Cancer Control; 2021; 28():10732748211038445. PubMed ID: 34569304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nomogram Based on Body Composition and Prognostic Nutritional Index Predicts Survival After Curative Resection of Gastric Cancer.
    Tao C; Hong W; Yin P; Wu S; Fan L; Lei Z; Yu Y
    Acad Radiol; 2024 May; 31(5):1940-1949. PubMed ID: 37981487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nomograms Combining Clinical and Imaging Parameters to Predict Recurrence and Disease-free Survival After Concurrent Chemoradiotherapy in Patients With Locally Advanced Cervical Cancer.
    Zhang Y; Liu L; Zhang K; Su R; Jia H; Qian L; Dong J
    Acad Radiol; 2023 Mar; 30(3):499-508. PubMed ID: 36050264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of a
    Liu H; Cui Y; Chang C; Zhou Z; Zhang Y; Ma C; Yin Y; Wang R
    BMC Cancer; 2024 Jan; 24(1):150. PubMed ID: 38291351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nomogram for Predicting Survival in Locally Advanced Cervical Cancer with Concurrent Chemoradiotherapy plus or Not Adjuvant Chemotherapy: A Retrospective Analysis Based on 2018 FIGO Staging.
    Hua L; Wei M; Feng C; Li S; Wen X; Chen S
    Cancer Biother Radiopharm; 2024 Jun; ():. PubMed ID: 38828494
    [No Abstract]   [Full Text] [Related]  

  • 10. Nomograms Predicting Progression-Free Survival, Overall Survival, and Pelvic Recurrence in Locally Advanced Cervical Cancer Developed From an Analysis of Identifiable Prognostic Factors in Patients From NRG Oncology/Gynecologic Oncology Group Randomized Trials of Chemoradiotherapy.
    Rose PG; Java J; Whitney CW; Stehman FB; Lanciano R; Thomas GM; DiSilvestro PA
    J Clin Oncol; 2015 Jul; 33(19):2136-42. PubMed ID: 25732170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes and prognostic factors in patients with locally advanced cervical cancer treated with concurrent chemoradiotherapy.
    Liu J; Tang G; Zhou Q; Kuang W
    Radiat Oncol; 2022 Aug; 17(1):142. PubMed ID: 35978412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of body composition and systemic inflammation for patients with locally advanced cervical cancer following concurrent chemoradiotherapy.
    Li J; Niu C; Zhang L; Mu Y; Gui X
    Diagn Interv Radiol; 2024 Sep; 30(5):279-290. PubMed ID: 38836436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of textural features obtained from F-fluorodeoxyglucose (F-18 FDG) positron emission tomography/computed tomography (PET/CT) in patients with locally advanced cervical cancer undergoing concurrent chemoradiotherapy.
    Cho HW; Lee ES; Lee JK; Eo JS; Kim S; Hong JH
    Ann Nucl Med; 2023 Jan; 37(1):44-51. PubMed ID: 36369325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival Nomograms after Curative Neoadjuvant Chemotherapy and Radical Surgery for Stage IB2-IIIB Cervical Cancer.
    Marchetti C; De Felice F; Di Pinto A; Romito A; Musella A; Palaia I; Monti M; Tombolin V; Muzii L; Benedetti Panici P
    Cancer Res Treat; 2018 Jul; 50(3):768-776. PubMed ID: 28724282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MRI-based radiomics value for predicting the survival of patients with locally advanced cervical squamous cell cancer treated with concurrent chemoradiotherapy.
    Zhang X; Zhao J; Zhang Q; Wang S; Zhang J; An J; Xie L; Yu X; Zhao X
    Cancer Imaging; 2022 Jul; 22(1):35. PubMed ID: 35842679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic prediction of oxidative stress related hematological biomarkers in locally advanced cervical cancer patients undergoing chemoradiotherapy.
    Wu G; Gu M; Zhu J; Gu R; Yang B; Ji S; Zhao Y; Gu K
    Biomarkers; 2024 Jul; 29(5):255-264. PubMed ID: 38767430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel nomogram based on body composition and nutritional indicators to predict the prognosis of patients with muscle-invasive bladder cancer undergoing radical cystectomy.
    Zhong X; Pan Y; Wu K; Wang L; Dou P; Tan P; Zhang P; Li X
    Cancer Med; 2023 Dec; 12(24):21627-21638. PubMed ID: 37975152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased visceral to subcutaneous fat ratio is associated with decreased overall survival in patients with metastatic melanoma receiving anti-angiogenic therapy.
    Grignol VP; Smith AD; Shlapak D; Zhang X; Del Campo SM; Carson WE
    Surg Oncol; 2015 Dec; 24(4):353-8. PubMed ID: 26690825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of metabolic parameters and textural analysis in predicting prognosis in locally advanced cervical cancer treated with chemoradiotherapy.
    Pedraza S; Seiffert AP; Sarandeses P; Muñoz-Lopez B; Gómez EJ; Sánchez-González P; Pérez-Regadera JF
    Strahlenther Onkol; 2022 Sep; 198(9):792-801. PubMed ID: 35072751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Multi-Institutional Retrospective Analysis of Oncologic Outcomes for Patients With Locally Advanced Cervical Cancer Undergoing Platinum-Based Adjuvant Chemotherapy After Concurrent Chemoradiotherapy.
    Wu N; Su X; Song H; Li Y; Gu F; Sun X; Li X; Cheng G
    Cancer Control; 2021; 28():1073274821989307. PubMed ID: 33593091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.